Medicare Enrolled

Dr. Babak Pazooki, MD

Endocrinology · Joliet, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2100 GLENWOOD AVE, Joliet, IL 60435
6307894910
In practice since 2006 (20 years)
NPI: 1396762316 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pazooki from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pazooki? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pazooki

Dr. Babak Pazooki is an endocrinology specialist in Joliet, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pazooki performed 4,107 Medicare services across 2,115 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pazooki received a total of $617,504 from 28 pharmaceutical and/or device companies across 1024 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pazooki is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 14% volume in IL $617,504 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,107
Medicare services
Top 14% in IL for endocrinology
2,115
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~205 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,500 $18 $27
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
477 $93 $229
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
399 $8 $20
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
356 $9 $50
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
196 $16 $86
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
194 $9 $46
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
120 $8 $44
Urine microalbumin test (kidney screening)
A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage.
117 $6 $30
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
117 $5 $27
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
116 $27 $91
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
112 $131 $307
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
95 $123 $359
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
63 $10 $62
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
49 $10 $55
Parathyroid hormone level test
A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones.
41 $40 $212
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
31 $29 $152
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
31 $72 $157
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
28 $89 $331
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
27 $13 $69
New patient office visit, complex (60-74 min) 25 $158 $443
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
13 $115 $305
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$617,504
Total received (2018-2024)
Avg $88,215/year across 7 years
Top 2% in IL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
1,024
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$614,892 (99.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,612 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$117,026
2023
$77,039
2022
$57,221
2021
$64,319
2020
$38,951
2019
$109,028
2018
$153,921

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$82,027
AstraZeneca Pharmaceuticals LP
$12,310
SANOFI-AVENTIS U.S. LLC
$11,882
Novo Nordisk Inc
$5,862
Abbott Laboratories
$4,377
Insulet Corporation
$109
Tolmar, Inc.
$108
Chiesi USA, Inc.
$94
Janssen Pharmaceuticals, Inc
$89
Dynavax Technologies Corporation
$82
Dexcom, Inc.
$52
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
ABBVIE INC.
$16
Top 3 companies account for 90.8% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$202,561
Lilly USA, LLC
$129,888
Novo Nordisk Inc
$113,328
AstraZeneca Pharmaceuticals LP
$78,740
Merck Sharp & Dohme Corporation
$33,954
Janssen Pharmaceuticals, Inc
$31,067
Abbott Laboratories
$20,853
Bayer HealthCare Pharmaceuticals Inc.
$4,940
Dexcom, Inc.
$299
Shire North American Group Inc
$206
Boehringer Ingelheim Pharmaceuticals, Inc.
$185
MannKind Corporation
$181
Insulet Corporation
$173
Corcept Therapeutics
$162
Becton, Dickinson and Company
$155
Amgen Inc.
$135
Bayer Healthcare Pharmaceuticals Inc.
$131
Tolmar, Inc.
$108
Amarin Pharma Inc.
$107
Chiesi USA, Inc.
$94
Dynavax Technologies Corporation
$82
Tandem Diabetes Care, Inc.
$38
Horizon Therapeutics plc
$32
Exact Sciences Corporation
$19
Medtronic MiniMed, Inc.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
ABBVIE INC.
$16
Medtronic, Inc.
$15
Top 3 companies account for 72.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BD NANO · BREZTRI · BYDUREON · Cologuard Collection Kit · DEXCOM G6 CGM SYSTEM · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · Enbrel · FARXIGA · FENSOLVI · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · HUMULIN · Heplisav-B · INVOKAMET · INVOKANA · JARDIANCE · Kerendia · Korlym · LANTUS · Levemir · MOUNJARO · MYCAPSSA · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · Omnipod · Ozempic · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOTAGLIFLOZIN · STEGLATRO · SYMBICORT · SYNTHROID · Saxenda · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Tresiba · Vascepa · Wegovy · XARELTO · XIFAXAN · XIGDUO · ZEPBOUND · iPro2 · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (100%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for endocrinology in IL.

Looking for an endocrinology specialist in Joliet?
Compare endocrinologists in the Joliet area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
55
Per 100K population
7.9
County median income
$107,799
Nearest hospital
SAINT JOSEPH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pazooki is a clinical cardiology specialist, with above-average Medicare volume (top 14% in IL), with speaking/promotional industry engagement in the top 2% of IL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pazooki experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Pazooki performed 1,500 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pazooki receive payments from pharmaceutical companies?
Yes. Dr. Pazooki received a total of $617,504 from 28 companies across 1,024 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pazooki's costs compare to other endocrinologists in Joliet?
Dr. Pazooki's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pazooki) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →